ArticleCancer research communications2024

Anti-HDGF Antibody Targets EGFR Tyrosine Kinase Inhibitor-Tolerant Cells in NSCLC Patient-Derived Xenografts.

Cindy Q Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.